Adverse pregnancy outcomes and long-term risk of cardiovascular disease in women

女性不良妊娠结局和心血管疾病的长期风险

基本信息

  • 批准号:
    10610456
  • 负责人:
  • 金额:
    $ 66.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-15 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

Pregnancy is a "natural stress test" that may reveal higher cardiovascular disease (CVD) risks in early adulthood, potentially long before the emergence of clinical CVD. Up to one-third of all pregnancies are affected by an adverse pregnancy outcome (APO), defined as preeclampsia, other hypertensive disorders, gestational diabetes, fetal growth restriction, and/or preterm delivery. Consequently, APOs affect >40 million women worldwide each year and nearly 30% of all women during their reproductive years. However, long-term CVD risks associated with APOs remain poorly understood and not well integrated into clinical practice. A better understanding could facilitate earlier interventions in young women and alter their long-term trajectory of CVD. Prior studies have been limited by insufficient phenotyping of APOs and CVD, follow-up time, and statistical power to assess long-term risks. Large cohorts are needed with prospective phenotyping of APOs and CVD before, during, and after pregnancy, and long-term follow-up. We hypothesize that APOs are associated with higher long-term CVD risks (ischemic heart disease, stroke, heart failure, arrhythmias, peripheral vascular disease) across the life course, independently of familial factors. To test this hypothesis, we propose to conduct the first comprehensive assessment of prospectively phenotyped APOs and long-term CVD risks in a large cohort with up to 48 years of follow-up. We will analyze national registry data for all 4.7 M pregnancies in 2.5 M women in Sweden during 1973-2017 and all inpatient and outpatient CVD diagnoses and mortality through 2020. Sweden is an ideal setting because it has linkable individual-level data for the entire population needed to enable this first-of-its-kind study, and CVD rates and mechanisms are comparable to the US. Our aims are to (1) determine associations between 4 major APOs (preeclampsia, other hypertensive disorders, gestational diabetes, fetal growth restriction) and long-term CVD risks across the life course; (2) identify high-risk subgroups of women who are most susceptible to effects of APOs on long-term CVD risks; (3) assess the influence of shared familial (genetic and/or environmental) factors; and (4) develop an integrated model for association of all 5 major APOs (including preterm delivery) with long-term CVD risks. The proposed research is significant because CVD is the leading cause of death in women worldwide, and APOs are common and potentially important sentinels of long-term CVD risks, yet such risks are understudied and poorly integrated into clinical practice. It is innovative because it will provide the first comprehensive assessment of prospectively phenotyped APOs and long-term CVD risks, utilize co-relative designs to disentangle familial confounding, and develop an integrated model for all 5 major APOs using unparalleled data for 2.5 M women. It is highly cost-efficient because we will leverage data from national registries in Sweden that are unavailable or prohibitively costly to assemble in the US. The results will will help improve women's health by identifying the long-term CVD risks associated with APOs needed to guide early prevention and long-term clinical care.
怀孕是一项“自然压力测试”,可能会揭示早期较高的心血管疾病 (CVD) 风险 成年期,可能早在临床心血管疾病出现之前。多达三分之一的怀孕是 受不良妊娠结局(APO)影响,定义为先兆子痫、其他高血压疾病、 妊娠糖尿病、胎​​儿生长受限和/或早产。因此,APO 影响超过 4000 万 每年全世界都有女性,其中近 30% 的女性处于育龄期。然而,长期来看 与 APO 相关的 CVD 风险仍然知之甚少,也没有很好地融入临床实践。一个 更好的理解可以促进对年轻女性的早期干预并改变她们的长期轨迹 化学气相沉积。先前的研究因 APO 和 CVD 的表型分析不足、随访时间和 评估长期风险的统计能力。 APO 的前瞻性表型分析需要大量队列 怀孕前、怀孕期间和怀孕后的CVD以及长期随访。我们假设 APO 是 与较高的长期 CVD 风险(缺血性心脏病、中风、心力衰竭、心律失常、 周围血管疾病)贯穿生命全程,与家族因素无关。为了检验这个假设, 我们建议对前瞻性表型 APO 和长期 大型队列的 CVD 风险长达 48 年的随访。我们将分析所有 470 万的国家登记数据 1973 年至 2017 年间瑞典 250 万妇女的怀孕情况以及所有住院和门诊 CVD 诊断和 到 2020 年的死亡率。瑞典是一个理想的环境,因为它拥有整个国家的可链接的个人层面数据 进行这项史无前例的研究所需的人群,CVD 发生率和机制与 我们。我们的目标是 (1) 确定 4 种主要 APO(先兆子痫、其他高血压)之间的关联 疾病、妊娠糖尿病、胎​​儿生长受限)和整个生命过程中的长期心血管疾病风险; (2) 确定最容易受到 APO 对长期 CVD 风险影响的女性高风险亚群; (3) 评估共同的家族(遗传和/或环境)因素的影响; (4) 开发集成的 所有 5 种主要 APO(包括早产)与长期 CVD 风险关联的模型。拟议的 研究意义重大,因为 CVD 是全世界女性死亡的主要原因,而 APO 是 长期 CVD 风险的常见且潜在重要的哨兵,但对此类风险的研究不足且不充分 融入临床实践。它是创新的,因为它将提供第一个全面的评估 前瞻性表型 APO 和长期 CVD 风险,利用相关设计来​​解开家族性 混淆,并使用 250 万女性的无与伦比的数据为所有 5 个主要 APO 开发一个综合模型。 它具有很高的成本效益,因为我们将利用瑞典国家登记处无法提供的数据 或者在美国组装成本高昂。研究结果将有助于改善女性健康 与 APO 相关的长期 CVD 风险需要指导早期预防和长期临床护理。

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Preterm birth and risk of chronic kidney disease from childhood into mid-adulthood: national cohort study.
早产和从童年到成年中期慢性肾病的风险:国家队列研究。
  • DOI:
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Crump, Casey;Sundquist, Jan;Winkleby, Marilyn A;Sundquist, Kristina
  • 通讯作者:
    Sundquist, Kristina
Pre-term delivery and long-term risk of heart failure in women: a national cohort and co-sibling study.
女性早产和心力衰竭的长期风险:一项全国队列和兄弟姐妹研究。
  • DOI:
  • 发表时间:
    2021-11-24
  • 期刊:
  • 影响因子:
    39.3
  • 作者:
    Crump, Casey;Sundquist, Jan;McLaughlin, Mary Ann;Dolan, Siobhan M;Sieh, Weiva;Sundquist, Kristina
  • 通讯作者:
    Sundquist, Kristina
Hypertension in Pregnancy Among Immigrant and Swedish Women: A Cohort Study of All Pregnant Women in Sweden.
移民和瑞典妇女妊娠期高血压:对瑞典所有孕妇的队列研究。
  • DOI:
  • 发表时间:
    2024-03-05
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Wändell, Per;Crump, Casey;Li, Xinjun;Stattin, Nouha Saleh;Carlsson, Axel C;Sundquist, Jan;Sundquist, Kristina
  • 通讯作者:
    Sundquist, Kristina
Preterm Delivery and Long-Term Risk of Stroke in Women: A National Cohort and Cosibling Study.
女性早产和长期中风风险:一项全国队列和共同研究。
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    37.8
  • 作者:
    Crump, Casey;Sundquist, Jan;Sundquist, Kristina
  • 通讯作者:
    Sundquist, Kristina
Preterm or Early Term Birth and Risk of Autism.
早产或早产与自闭症风险。
  • DOI:
  • 发表时间:
    2021-09
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Crump, Casey;Sundquist, Jan;Sundquist, Kristina
  • 通讯作者:
    Sundquist, Kristina
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Casey Crump其他文献

Casey Crump的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Casey Crump', 18)}}的其他基金

Mental Health Outcomes in Alzheimer's Disease Patients and Their Partners
阿尔茨海默病患者及其伴侣的心理健康结果
  • 批准号:
    10726776
  • 财政年份:
    2023
  • 资助金额:
    $ 66.33万
  • 项目类别:
Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners
前列腺癌幸存者及其伴侣的长期心理健康结果
  • 批准号:
    10416343
  • 财政年份:
    2022
  • 资助金额:
    $ 66.33万
  • 项目类别:
Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners
前列腺癌幸存者及其伴侣的长期心理健康结果
  • 批准号:
    10650842
  • 财政年份:
    2022
  • 资助金额:
    $ 66.33万
  • 项目类别:
Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners
前列腺癌幸存者及其伴侣的长期心理健康结果
  • 批准号:
    10908089
  • 财政年份:
    2022
  • 资助金额:
    $ 66.33万
  • 项目类别:
Preterm birth and long-term risk of cardiovascular disease in mothers and offspring
母亲和后代的早产和心血管疾病的长期风险
  • 批准号:
    9926123
  • 财政年份:
    2018
  • 资助金额:
    $ 66.33万
  • 项目类别:
Preterm birth and long-term risk of cardiovascular disease in mothers and offspring
母亲和后代的早产和心血管疾病的长期风险
  • 批准号:
    9592417
  • 财政年份:
    2018
  • 资助金额:
    $ 66.33万
  • 项目类别:
Preterm birth and long-term risk of cardiovascular disease in mothers and offspring
母亲和后代的早产和心血管疾病的长期风险
  • 批准号:
    9759973
  • 财政年份:
    2018
  • 资助金额:
    $ 66.33万
  • 项目类别:
Adverse pregnancy outcomes and long-term risk of cardiovascular disease in women
女性不良妊娠结局和心血管疾病的长期风险
  • 批准号:
    10446071
  • 财政年份:
    2018
  • 资助金额:
    $ 66.33万
  • 项目类别:
Preterm birth and long-term risk of cardiovascular disease in mothers and offspring
母亲和后代的早产和心血管疾病的长期风险
  • 批准号:
    10155552
  • 财政年份:
    2018
  • 资助金额:
    $ 66.33万
  • 项目类别:
Discovering and Characterizing Novel Pregnancy-Associated Cancers
发现和表征新的与妊娠相关的癌症
  • 批准号:
    9330818
  • 财政年份:
    2016
  • 资助金额:
    $ 66.33万
  • 项目类别:

相似国自然基金

基于lncRNA NONHSAT042241/hnRNP D/β-catenin轴探讨雷公藤衍生物(LLDT-8)对类风湿关节炎滑膜成纤维细胞功能影响及机制研究
  • 批准号:
    82304988
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
针刺手法和参数对针刺效应启动的影响及其机制
  • 批准号:
    82305416
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
二仙汤影响肾上腺皮质-髓质激素分泌及调控下丘脑温度感受器以缓解“天癸竭”潮热的研究
  • 批准号:
    82374307
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
固定翼海空跨域航行器出水稳定性与流体动力载荷影响机制
  • 批准号:
    52371327
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
经济制裁对跨国企业海外研发网络建构的影响:基于被制裁企业的视角
  • 批准号:
    72302155
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

PAGE-G: Precision Approach combining Genes and Environment in Glaucoma
PAGE-G:青光眼基因与环境相结合的精准方法
  • 批准号:
    10797646
  • 财政年份:
    2023
  • 资助金额:
    $ 66.33万
  • 项目类别:
Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA)
芝加哥不同高危女性人群乳腺癌替代预防研究 (CAPSBRACA)
  • 批准号:
    10737279
  • 财政年份:
    2023
  • 资助金额:
    $ 66.33万
  • 项目类别:
Genetic and Environmental Influences on Individual Sweet Preference Across Ancestry Groups in the U.S.
遗传和环境对美国不同血统群体个体甜味偏好的影响
  • 批准号:
    10709381
  • 财政年份:
    2023
  • 资助金额:
    $ 66.33万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 66.33万
  • 项目类别:
Non-APOL1 genetic factors and kidney transplant outcomes
非 APOL1 遗传因素与肾移植结果
  • 批准号:
    10717171
  • 财政年份:
    2023
  • 资助金额:
    $ 66.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了